Complement-binding donor epitope sharing antibodies in a kidney transplant recipient.
作者信息
Hwang Seon Deok, Lee Myoung Hyun, Chung Byung Ha, Kim Yonggoo, Han Kyungja, Yang Chul Woo, Oh Eun-Jee
机构信息
Department of Transplant Research Centre and Division of Nephrology, Department of Internal Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Department of Laboratory Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
出版信息
Blood Transfus. 2015 Jan;13(1):161-3. doi: 10.2450/2014.0142-14. Epub 2014 Oct 29.
Abstract
摘要
相似文献
1
Complement-binding donor epitope sharing antibodies in a kidney transplant recipient.
Blood Transfus. 2015 Jan;13(1):161-3. doi: 10.2450/2014.0142-14. Epub 2014 Oct 29.
2
Epitope Analysis Aids in Transplant Decision Making by Determining the Clinical Relevance of Apparent Pre-Transplant Donor Specific Antibodies (DSA).
Ann Clin Lab Sci. 2019 Jan;49(1):50-56.
3
Detection of donor-specific antibodies in kidney transplantation.
Br Med Bull. 2014 Jun;110(1):23-34. doi: 10.1093/bmb/ldu005. Epub 2014 Apr 15.
4
The complement interference phenomenon as a cause for sharp fluctuations of serum anti-HLA antibody strength in kidney transplant patients.
Transpl Immunol. 2013 Dec;29(1-4):17-21. doi: 10.1016/j.trim.2013.09.005. Epub 2013 Sep 20.
5
[New aspects of HLA compatibility in organ transplantation].
Nephrol Ther. 2016 Apr;12 Suppl 1:S125-30. doi: 10.1016/j.nephro.2016.01.006. Epub 2016 Mar 8.
6
Anti-HLA Antibody: The Role of Epitopes in Organ Transplantation.
Exp Clin Transplant. 2019 Jan;17(Suppl 1):38-42. doi: 10.6002/ect.MESOT2018.L41.
7
Clinical relevance of human leukocyte antigen antibodies in kidney transplantation from deceased donors: the North Italy Transplant program approach.
Hum Immunol. 2009 Aug;70(8):631-5. doi: 10.1016/j.humimm.2009.06.006. Epub 2009 Jun 12.
8
Defining the immunogenicity and antigenicity of HLA epitopes is crucial for optimal epitope matching in clinical renal transplantation.
HLA. 2017 Jul;90(1):5-16. doi: 10.1111/tan.13038. Epub 2017 Apr 5.
9
The Humoral Theory of Transplantation: Epitope Analysis and the Pathogenicity of HLA Antibodies.
J Immunol Res. 2016;2016:5197396. doi: 10.1155/2016/5197396. Epub 2016 Dec 14.
10
Which is the best predictor of de novo donor-specific antibodies in a cohort of non-sensitized first kidney transplantation: Antigenic, allelic, epitope, or physiochemical HLA mismatches?
Clin Transplant. 2019 Apr;33(4):e13508. doi: 10.1111/ctr.13508. Epub 2019 Mar 22.
本文引用的文献
1
Structural aspects of HLA class I epitopes reacting with human monoclonal antibodies in Ig-binding, C1q-binding and lymphocytotoxicity assays.
Hum Immunol. 2013 Oct;74(10):1271-9. doi: 10.1016/j.humimm.2013.05.016. Epub 2013 Jun 12.
2
Human leukocyte antigen epitope analysis to assess complement- and non-complement-binding donor-specific antibody repertoire in a pediatric heart transplant recipient.
Hum Immunol. 2012 Jan;73(1):48-51. doi: 10.1016/j.humimm.2011.10.011. Epub 2011 Oct 28.
3
Complement-fixing donor-specific antibodies identified by a novel C1q assay are associated with allograft loss.
Pediatr Transplant. 2012 Feb;16(1):12-7. doi: 10.1111/j.1399-3046.2011.01599.x. Epub 2011 Nov 17.
4
Donor-specific HLA class I and CREG antibodies in complement-dependent cytotoxicity-negative renal transplants.
Ann Clin Lab Sci. 2010 Fall;40(4):330-5.
5
Specific "intra-allele" and "intra-broad antigen" human leukocyte antigen alloantibodies in kidney graft transplantation.
Hum Immunol. 2010 Sep;71(9):857-60. doi: 10.1016/j.humimm.2010.05.018. Epub 2010 May 25.
Zotero 插件